BMY Annual FCF
$12.65 B
+$703.00 M+5.88%
31 December 2023
Summary:
As of January 22, 2025, BMY annual free cash flow is $12.65 billion, with the most recent change of +$703.00 million (+5.88%) on December 31, 2023. During the last 3 years, it has fallen by -$648.00 million (-4.87%). BMY annual FCF is now -16.96% below its all-time high of $15.23 billion, reached on December 31, 2021.BMY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Quarterly FCF
$5.27 B
+$3.20 B+155.18%
30 September 2024
Summary:
As of January 22, 2025, BMY quarterly free cash flow is $5.27 billion, with the most recent change of +$3.20 billion (+155.18%) on September 30, 2024. Over the past year, it has increased by +$1.34 billion (+34.29%). BMY quarterly FCF is now at all-time high.BMY Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY TTM FCF
$13.80 B
+$858.00 M+6.63%
30 September 2024
Summary:
As of January 22, 2025, BMY TTM free cash flow is $13.80 billion, with the most recent change of +$858.00 million (+6.63%) on September 30, 2024. Over the past year, it has increased by +$1.15 billion (+9.11%). BMY TTM FCF is now -9.39% below its all-time high of $15.23 billion, reached on December 31, 2021.BMY TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +5.9% | +34.3% | +9.1% |
3 y3 years | -4.9% | +34.3% | +9.1% |
5 y5 years | +106.9% | +34.3% | +9.1% |
BMY Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -17.0% | +5.9% | at high | +223.5% | -9.4% | +28.8% |
5 y | 5-year | -17.0% | +71.6% | at high | +223.5% | -9.4% | +87.2% |
alltime | all time | -17.0% | +5438.0% | at high | +506.1% | -9.4% | +5924.1% |
Bristol-Myers Squibb Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $5.27 B(+155.2%) | $13.80 B(+6.6%) |
June 2024 | - | $2.06 B(-19.1%) | $12.95 B(+3.5%) |
Mar 2024 | - | $2.55 B(-35.0%) | $12.51 B(-1.1%) |
Dec 2023 | $12.65 B(+5.9%) | $3.92 B(-11.0%) | $12.65 B(+8.2%) |
Sept 2023 | - | $4.41 B(+170.8%) | $11.69 B(+9.0%) |
June 2023 | - | $1.63 B(-39.5%) | $10.72 B(-3.3%) |
Mar 2023 | - | $2.69 B(-9.1%) | $11.08 B(-7.3%) |
Dec 2022 | $11.95 B(-21.6%) | $2.96 B(-14.0%) | $11.95 B(-6.1%) |
Sept 2022 | - | $3.44 B(+73.0%) | $12.72 B(-10.9%) |
June 2022 | - | $1.99 B(-44.1%) | $14.28 B(-5.7%) |
Mar 2022 | - | $3.56 B(-4.8%) | $15.14 B(-0.6%) |
Dec 2021 | $15.23 B(+14.5%) | $3.74 B(-25.2%) | $15.23 B(+4.6%) |
Sept 2021 | - | $5.00 B(+75.3%) | $14.57 B(+24.7%) |
June 2021 | - | $2.85 B(-21.9%) | $11.69 B(-11.5%) |
Mar 2021 | - | $3.65 B(+18.8%) | $13.20 B(-0.8%) |
Dec 2020 | $13.30 B(+80.3%) | $3.07 B(+45.3%) | $13.30 B(+9.4%) |
Sept 2020 | - | $2.11 B(-51.5%) | $12.16 B(-2.0%) |
June 2020 | - | $4.36 B(+16.3%) | $12.41 B(+24.9%) |
Mar 2020 | - | $3.75 B(+94.4%) | $9.94 B(+34.8%) |
Dec 2019 | $7.37 B(+20.6%) | $1.93 B(-18.4%) | $7.37 B(-15.3%) |
Sept 2019 | - | $2.37 B(+25.1%) | $8.71 B(+17.7%) |
June 2019 | - | $1.89 B(+59.5%) | $7.40 B(+16.2%) |
Mar 2019 | - | $1.19 B(-63.7%) | $6.37 B(+4.1%) |
Dec 2018 | $6.12 B(+44.9%) | $3.27 B(+209.5%) | $6.12 B(+64.7%) |
Sept 2018 | - | $1.05 B(+22.8%) | $3.71 B(-9.6%) |
June 2018 | - | $859.00 M(-8.2%) | $4.11 B(-10.4%) |
Mar 2018 | - | $936.00 M(+8.5%) | $4.59 B(+8.7%) |
Dec 2017 | $4.22 B(+129.0%) | $863.00 M(-40.5%) | $4.22 B(-4.7%) |
Sept 2017 | - | $1.45 B(+8.6%) | $4.43 B(+9.6%) |
June 2017 | - | $1.34 B(+134.4%) | $4.04 B(+40.2%) |
Mar 2017 | - | $570.00 M(-46.8%) | $2.88 B(+56.4%) |
Dec 2016 | $1.84 B(+43.4%) | $1.07 B(+0.8%) | $1.84 B(+34.5%) |
Sept 2016 | - | $1.06 B(+497.2%) | $1.37 B(+129.5%) |
June 2016 | - | $178.00 M(-137.9%) | $597.00 M(+83.7%) |
Mar 2016 | - | -$470.00 M(-178.5%) | $325.00 M(-74.7%) |
Dec 2015 | $1.28 B(-51.0%) | $599.00 M(+106.6%) | $1.28 B(+20.4%) |
Sept 2015 | - | $290.00 M(-408.5%) | $1.07 B(-32.2%) |
June 2015 | - | -$94.00 M(-119.2%) | $1.57 B(-39.8%) |
Mar 2015 | - | $490.00 M(+28.6%) | $2.61 B(-0.3%) |
Dec 2014 | $2.62 B(-12.8%) | $381.00 M(-52.1%) | $2.62 B(-24.0%) |
Sept 2014 | - | $796.00 M(-15.9%) | $3.45 B(-3.7%) |
June 2014 | - | $946.00 M(+89.6%) | $3.58 B(-11.5%) |
Mar 2014 | - | $499.00 M(-58.8%) | $4.05 B(+34.6%) |
Dec 2013 | $3.01 B(-52.9%) | $1.21 B(+30.2%) | $3.01 B(+22.3%) |
Sept 2013 | - | $929.00 M(-34.2%) | $2.46 B(-58.9%) |
June 2013 | - | $1.41 B(-360.0%) | $5.98 B(+7.0%) |
Mar 2013 | - | -$543.00 M(-182.1%) | $5.59 B(-12.6%) |
Dec 2012 | $6.39 B(+42.9%) | $661.00 M(-85.1%) | $6.39 B(-10.8%) |
Sept 2012 | - | $4.45 B(+335.6%) | $7.17 B(+65.4%) |
June 2012 | - | $1.02 B(+286.7%) | $4.33 B(+0.0%) |
Mar 2012 | - | $264.00 M(-81.6%) | $4.33 B(-3.2%) |
Dec 2011 | $4.47 B(+10.0%) | $1.43 B(-11.2%) | $4.47 B(-0.8%) |
Sept 2011 | - | $1.61 B(+58.4%) | $4.51 B(+7.6%) |
June 2011 | - | $1.02 B(+151.0%) | $4.19 B(+1.2%) |
Mar 2011 | - | $406.00 M(-72.4%) | $4.14 B(+1.7%) |
Dec 2010 | $4.07 B(+21.9%) | $1.47 B(+13.6%) | $4.07 B(+8.6%) |
Sept 2010 | - | $1.29 B(+33.7%) | $3.75 B(-0.3%) |
June 2010 | - | $968.00 M(+189.0%) | $3.75 B(+9.8%) |
Mar 2010 | - | $335.00 M(-70.8%) | $3.42 B(+2.5%) |
Dec 2009 | $3.33 B(+20.6%) | $1.15 B(-12.0%) | $3.33 B(+47.0%) |
Sept 2009 | - | $1.30 B(+106.3%) | $2.27 B(+2.2%) |
June 2009 | - | $632.00 M(+151.8%) | $2.22 B(-10.9%) |
Mar 2009 | - | $251.00 M(+209.9%) | $2.49 B(-9.9%) |
Dec 2008 | $2.77 B(+19.7%) | $81.00 M(-93.6%) | $2.77 B(-9.8%) |
Sept 2008 | - | $1.26 B(+38.9%) | $3.06 B(+32.1%) |
June 2008 | - | $904.00 M(+72.2%) | $2.32 B(+2.2%) |
Mar 2008 | - | $525.00 M(+38.2%) | $2.27 B(-1.6%) |
Dec 2007 | $2.31 B | $380.00 M(-25.8%) | $2.31 B(+20.6%) |
Sept 2007 | - | $512.00 M(-40.1%) | $1.92 B(-10.8%) |
June 2007 | - | $855.00 M(+51.9%) | $2.15 B(+8.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $563.00 M(-3853.3%) | $1.97 B(+52.9%) |
Dec 2006 | $1.29 B(+20.8%) | -$15.00 M(-102.0%) | $1.29 B(-7.8%) |
Sept 2006 | - | $744.00 M(+9.4%) | $1.40 B(+13.8%) |
June 2006 | - | $680.00 M(-671.4%) | $1.23 B(+254.2%) |
Mar 2006 | - | -$119.00 M(-226.6%) | $347.00 M(-67.5%) |
Dec 2005 | $1.07 B(-54.9%) | $94.00 M(-83.6%) | $1.07 B(-26.5%) |
Sept 2005 | - | $574.00 M(-384.2%) | $1.45 B(+25.6%) |
June 2005 | - | -$202.00 M(-133.6%) | $1.16 B(-43.5%) |
Mar 2005 | - | $602.00 M(+25.4%) | $2.05 B(-13.4%) |
Dec 2004 | $2.37 B(-6.1%) | $480.00 M(+72.7%) | $2.37 B(-15.7%) |
Sept 2004 | - | $278.00 M(-59.8%) | $2.81 B(-13.2%) |
June 2004 | - | $691.00 M(-24.7%) | $3.23 B(-7.4%) |
Mar 2004 | - | $918.00 M(-0.4%) | $3.49 B(+38.5%) |
Dec 2003 | $2.52 B(-1164.1%) | $922.00 M(+31.0%) | $2.52 B(+38.6%) |
Sept 2003 | - | $704.00 M(-25.8%) | $1.82 B(+0.2%) |
June 2003 | - | $949.00 M(-1890.6%) | $1.82 B(+80.3%) |
Mar 2003 | - | -$53.00 M(-124.1%) | $1.01 B(-524.9%) |
Dec 2002 | -$237.00 M(-105.4%) | $220.00 M(-68.6%) | -$237.00 M(-120.2%) |
Sept 2002 | - | $700.00 M(+400.0%) | $1.17 B(-6.2%) |
June 2002 | - | $140.00 M(-110.8%) | $1.25 B(-47.7%) |
Mar 2002 | - | -$1.30 B(-179.6%) | $2.39 B(-45.5%) |
Dec 2001 | $4.38 B(+7.8%) | $1.63 B(+109.8%) | $4.38 B(+1.6%) |
Sept 2001 | - | $777.00 M(-39.2%) | $4.31 B(-5.9%) |
June 2001 | - | $1.28 B(+84.1%) | $4.58 B(+10.6%) |
Mar 2001 | - | $694.00 M(-55.6%) | $4.14 B(+1.9%) |
Dec 2000 | $4.06 B(+15.6%) | $1.56 B(+48.9%) | $4.06 B(+7.0%) |
Sept 2000 | - | $1.05 B(+25.3%) | $3.80 B(+3.2%) |
June 2000 | - | $837.00 M(+36.1%) | $3.68 B(+4.2%) |
Mar 2000 | - | $615.00 M(-52.5%) | $3.53 B(+0.5%) |
Dec 1999 | $3.52 B(+17.4%) | $1.30 B(+39.1%) | $3.52 B(+14.4%) |
Sept 1999 | - | $932.00 M(+35.5%) | $3.07 B(-6.5%) |
June 1999 | - | $688.00 M(+14.9%) | $3.29 B(+14.7%) |
Mar 1999 | - | $599.00 M(-29.9%) | $2.87 B(-4.2%) |
Dec 1998 | $2.99 B(+75.2%) | $854.00 M(-25.5%) | $2.99 B(+24.5%) |
Sept 1998 | - | $1.15 B(+329.6%) | $2.40 B(+25.7%) |
June 1998 | - | $267.00 M(-63.2%) | $1.91 B(+2.4%) |
Mar 1998 | - | $726.00 M(+175.0%) | $1.87 B(+9.4%) |
Dec 1997 | $1.71 B(-16.2%) | $264.00 M(-59.8%) | $1.71 B(-9.6%) |
Sept 1997 | - | $656.00 M(+194.2%) | $1.89 B(+2.8%) |
June 1997 | - | $223.00 M(-60.6%) | $1.84 B(-12.7%) |
Mar 1997 | - | $566.00 M(+27.2%) | $2.11 B(+3.2%) |
Dec 1996 | $2.04 B(+2.7%) | $445.00 M(-26.3%) | $2.04 B(-0.8%) |
Sept 1996 | - | $604.00 M(+23.0%) | $2.06 B(-2.0%) |
June 1996 | - | $491.00 M(-1.8%) | $2.10 B(+15.0%) |
Mar 1996 | - | $500.00 M(+8.5%) | $1.82 B(-8.2%) |
Dec 1995 | $1.99 B(+14.9%) | $461.00 M(-28.5%) | $1.99 B(-0.1%) |
Sept 1995 | - | $645.00 M(+197.2%) | $1.99 B(+18.0%) |
June 1995 | - | $217.00 M(-67.3%) | $1.69 B(-6.5%) |
Mar 1995 | - | $663.00 M(+43.2%) | $1.80 B(+4.3%) |
Dec 1994 | $1.73 B(-14.0%) | $463.00 M(+35.4%) | $1.73 B(-4.8%) |
Sept 1994 | - | $342.00 M(+2.4%) | $1.82 B(-15.6%) |
June 1994 | - | $334.00 M(-43.3%) | $2.15 B(-6.1%) |
Mar 1994 | - | $589.00 M(+6.9%) | $2.29 B(+14.0%) |
Dec 1993 | $2.01 B(+45.5%) | $551.00 M(-18.7%) | $2.01 B(+4.9%) |
Sept 1993 | - | $678.00 M(+43.3%) | $1.92 B(+8.6%) |
June 1993 | - | $473.00 M(+53.6%) | $1.76 B(+24.9%) |
Mar 1993 | - | $308.00 M(-32.8%) | $1.41 B(+2.3%) |
Dec 1992 | $1.38 B(+14.4%) | $458.00 M(-12.9%) | $1.38 B(+2.1%) |
Sept 1992 | - | $526.00 M(+334.7%) | $1.35 B(+14.0%) |
June 1992 | - | $121.00 M(-56.2%) | $1.19 B(-2.6%) |
Mar 1992 | - | $276.00 M(-35.7%) | $1.22 B(+0.9%) |
Dec 1991 | $1.21 B(-2.6%) | $429.00 M(+19.2%) | $1.21 B(+4.8%) |
Sept 1991 | - | $360.00 M(+135.3%) | $1.15 B(+2.3%) |
June 1991 | - | $153.00 M(-42.3%) | $1.13 B(-8.9%) |
Mar 1991 | - | $265.00 M(-29.1%) | $1.24 B(-0.2%) |
Dec 1990 | $1.24 B(+95.1%) | $374.00 M(+12.0%) | $1.24 B(+43.2%) |
Sept 1990 | - | $334.00 M(+27.0%) | $865.00 M(+62.9%) |
June 1990 | - | $263.00 M(-1.9%) | $531.00 M(+98.1%) |
Mar 1990 | - | $268.00 M | $268.00 M |
Dec 1989 | $635.00 M | - | - |
FAQ
- What is Bristol-Myers Squibb annual free cash flow?
- What is the all time high annual FCF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual FCF year-on-year change?
- What is Bristol-Myers Squibb quarterly free cash flow?
- What is the all time high quarterly FCF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly FCF year-on-year change?
- What is Bristol-Myers Squibb TTM free cash flow?
- What is the all time high TTM FCF for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM FCF year-on-year change?
What is Bristol-Myers Squibb annual free cash flow?
The current annual FCF of BMY is $12.65 B
What is the all time high annual FCF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual free cash flow is $15.23 B
What is Bristol-Myers Squibb annual FCF year-on-year change?
Over the past year, BMY annual free cash flow has changed by +$703.00 M (+5.88%)
What is Bristol-Myers Squibb quarterly free cash flow?
The current quarterly FCF of BMY is $5.27 B
What is the all time high quarterly FCF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly free cash flow is $5.27 B
What is Bristol-Myers Squibb quarterly FCF year-on-year change?
Over the past year, BMY quarterly free cash flow has changed by +$1.34 B (+34.29%)
What is Bristol-Myers Squibb TTM free cash flow?
The current TTM FCF of BMY is $13.80 B
What is the all time high TTM FCF for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM free cash flow is $15.23 B
What is Bristol-Myers Squibb TTM FCF year-on-year change?
Over the past year, BMY TTM free cash flow has changed by +$1.15 B (+9.11%)